04/22/2024
4:20 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:20 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:20 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
2:17 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
2:24 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
2:13 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:16 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/02/2024
2:58 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | PTC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:20 PM | Bell William F. Jr. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:25 PM | PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:10 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:11 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:16 PM | Okey Stephanie (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:50 PM | ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
6:13 AM | PTC Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/08/2024
9:17 AM | PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/30/2024
2:17 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:18 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:18 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
2:25 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
3:30 PM | Jacobson Allan Steven (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
12:11 PM | PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:06 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:08 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:09 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:10 PM | PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:11 PM | PTC Therapeutics (Issuer)
Utter Christine Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:53 AM | FMR LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024
4:46 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:35 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:29 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:30 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:33 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:16 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:17 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:23 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
01/08/2024
3:47 PM | Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:35 PM | BlackRock Inc. (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
3:37 PM | Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:46 PM | PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:29 PM | Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:34 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:35 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:46 AM | PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:27 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
2:17 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
4:12 PM | Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:38 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:02 AM | FMR LLC (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2023
3:16 PM | PTC Therapeutics (Filer)
| Form POSASR | |
10/30/2023
8:05 AM | Camber Capital Management LP (Filed by)
PTC Therapeutics (Subject)
| Form SC 13G | |
10/26/2023
3:34 PM | PTC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023
3:15 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
7:03 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:45 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
8:00 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
5:15 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:34 PM | PTC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2023
11:00 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:46 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:49 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2023
3:51 PM | Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
6:30 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:41 PM | ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Filed by)
| Form SC 13D/A | |
06/13/2023
3:26 PM | Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/07/2023
10:49 AM | PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
7:23 AM | ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023
3:12 PM | PTC Therapeutics (Issuer)
Reeve Emma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:36 PM | PTC Therapeutics (Subject)
Reeve Emma (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023
4:17 PM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
3:05 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:14 PM | PTC Therapeutics (Subject)
Reeve Emma (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2023
4:24 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
3:43 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/18/2023
3:37 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
4:39 PM | Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
6:04 AM | PTC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
11:40 AM | Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023
9:31 AM | PTC Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/05/2023
3:31 PM | PTC Therapeutics (Filer)
| Form S-3ASR | |
04/26/2023
7:32 AM | PTC Therapeutics (Filer)
| Form ARS | |
04/26/2023
7:22 AM | PTC Therapeutics (Filer)
| Form DEF 14A | |
04/26/2023
7:24 AM | PTC Therapeutics (Filer)
| Form DEFA14A | |
